China

VIDEO: Chinese military plane comes ‘dangerously’ close to U.S. aircraft over South China Sea

Published

5 months ago

December 30, 2022

The United States Army recorded and released unnerving video of a close encounter with a Chinese jet over the South China Sea. The Chinese military plane came “dangerously” close to the U.S. military aircraft in the international airspace last week, the U.S. military announced on Thursday.

US, Chinese jets in close encounter over South China Sea pic.twitter.com/X8fbV84neF

— PressTV Extra (@PresstvExtra) December 29, 2022

The Indo-Pacific Command (INDOPACOM), the command responsible for overseeing U.S. operations in the area, said in a statement that the encounter occurred on December 21, during which a Chinese Navy J-11 fighter jet flew within 10 feet (3 meters) of a U.S. Air Force RC-135, a reconnaissance plane with about 30 people on board.

According to a U.S. military spokesperson, the Chinese jet came within 10 feet of the airplane’s wing, but 20 feet from its nose, causing the U.S. aircraft to take evasive maneuvers to avoid a collision.

China

FDA will work with China to import cancer drugs due to U.S. shortages

Published

2 days ago

June 7, 2023

Sara Carter Staff

Earlier this week the United States Food and Drug Administration (FDA) announced it will be working to import chemotherapy drugs from, of all places, China. The drug, called Cisplatin, is to help “ramp up supply amidst rampant drug shortages in the U.S.” reports Foreign Desk News.

Foreign Desk News writes:

Cisplatin comes from drugmaker Qilu Pharmaceutical, which is marketed and produced in China but has not been approved by the FDA. According to a May 24 letter, Qilu will work with the Canadian-based drug company Apotex to import and distribute the medication, which will come in 50-milligram vials with Chinese labels.

“The FDA is responding to yet another generic drug shortage,” said Edmund F. Haislmaier, an expert in healthcare policy and markets at The Heritage Foundation. “The underlying cause of those shortages is that generic drugs have become low-margin commodity products,” he added.

Last week on Twitter, FDA commissioner Dr. Robert Califf said the partnership with Qilu Pharmaceutical is temporary but will provide patients with a potentially life-extending drug.

“The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages,” Califf said.

The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages. https://t.co/8XvOuJzSL4

— Dr. Robert M. Califf (@DrCaliff_FDA) June 3, 2023

Foreign Desk News adds:

The latest move by the FDA is sure to spark concern and debate in Congress, as lawmakers in the House and Senate have called on the Biden administration to de-couple the U.S. economy from the Chinese markets, given Beijing’s aggressive push to expand in the South-China Sea and eventually take over the island state of Taiwan. China has also spread illegal and dangerous synthetic opioids and fentanyl drugs across the U.S. southern border, resulting in the devastating deaths of many Americans.